on DBV TECHNOLOGIES (EPA:DBV)
DBV Technologies to Meet with Investors in November
DBV Technologies, a biopharmaceutical company listed on Euronext and Nasdaq, announces its participation in two investor conferences in November 2026. On November 9, the company will be in Boston for the 3rd annual Guggenheim Securities Healthcare Innovation Conference, where it will participate in an informal discussion. On November 16, DBV Technologies will attend the LifeSci Growth & Innovation Summit in London for one-on-one meetings.
For those unable to attend in person, DBV Technologies will offer a live webcast of the "fireside chat." This content will be available on their website for 90 days after the event.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DBV TECHNOLOGIES news